Updated: January 17, 2022
National Institutes of Health (NIH) |
||
|---|---|---|
| PA-18-935 | Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) | |
| PA-18-591 |
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
|
| NOT-MD-20-025 |
Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities |
Expires 5/8/2023 |
| NOT-DC-20-008 |
Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders |
Expires 9/8/2022 |
| NOT-TR-20-017 |
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus |
Expires 1/26/2022 |
| NOT-TR-20-016 |
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus |
Expires 1/26/2022 |
| PA-20-135 |
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) |
9/8/2025 |
National Science Foundation (NSF) |
|
|---|---|
| — | NSF Supporting Research to Address Coronavirus Disease - blog post |
| NSF 20-052 | Dear Colleague Letter to researchers inviting additional proposals |
| NSF 20-055 | Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) |
| — | Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Proposers and Awardees |
Department of Energy |
|
|---|---|
| — | DOE Statement |
Department of Defense |
||
|---|---|---|
| — | — | |
Other Coronavirus Funding Opportunities |
||
|---|---|---|
| COVID-19 Early Treatment Fund |
The only organization in the world that exclusively funds outpatient clinical trials for COVID-19, CETF is narrowly focused on ensuring that outpatient trials for top drugs are successful, seeking the quickest, safest and lowest-cost way to repurpose drugs to dramatically reduce hospitalization rates. |
Not accepting new grant applications at this time; visit link to sign up for notifications. |
| Fast Grants | Fast Funding for COVID-19 Science The Rush Office of Philanthropy coordinates proposals to private foundations. Please contact Mary Marron at mary_marron@rush.edu. |
On hold since 4/14; visit link to sign up for notifications. |